Agent Capital

Investor type

VC

Founded

2016

AUM

$63 M

Location

Boston, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Series A Seed Pre-seed Late Stage (Series C+)

Region of investment

Europe North America Asia
Investor profile last updated: 16 August, 2026

Profile

Agent Capital is a healthcare venture capital firm based in Boston. Founded by Dr. Geeta Vemuri and Dr. Preston Noon, the firm emphasizes building transformative healthcare solutions that address unmet medical needs. Their core team, consisting of experts in biopharma and life sciences, leverages a deep understanding of industry pressures and trends, setting them apart in their investment approach. The founders bring significant experience from their past roles at Baxter Ventures, Baxalta Ventures, and other key positions within the pharmaceutical industry.

Agent Capital primarily invests in therapeutics at various stages of development, ranging from preclinical to commercial phases. They focus on areas such as rare diseases, oncology, neurology, and immunology. The firm does not confine itself to any specific geographical boundaries. While exact AUM details are not specified, Agent Capital's impact on the advancement of healthcare treatments is evident in their strategic partnerships.

Notable investments include Dice Therapeutics, Freenome, Metagenomi, Pliant Therapeutics, and Skyhawk Therapeutics. The firm is consistently recognized for its contribution to the biopharma sector by backing science-driven innovations that have transformative potential. These investments showcase their commitment to pioneering therapies that shape the future of patient care.

Industry

Healthcare Services Biotechnology Medical Devices Pharmaceuticals AI Life Sciences HealthTech Technology

Agent Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Agent Capital Fund I
Venture Capital (VC)
Healthcare Services
AI
Technology
Life Sciences
Seed
Series A
Series B
North America
$5-10 m
$63 M
June 2017

Contacts

Name
Title
Email
avatar
Preston Noon General Partner, Co-Founder
General Partner, Co-Founder
p•••@•••
avatar
Geeta Vemuri Founder and Managing Partner
Founder and Managing Partner
g•••@•••
Upgrade to see contacts
avatar
wfMWRBcuZygrmtQh wfMWRBcuZygrmtQh
wfMWRBcuZygrmtQh
avatar
wfMWRBcuZygrmtQh wfMWRBcuZygrmtQh
wfMWRBcuZygrmtQh
avatar
wfMWRBcuZygrmtQh wfMWRBcuZygrmtQh
wfMWRBcuZygrmtQh
Investment-team contacts for Agent Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Agent Capital

Agent Capital is a venture capital firm. It backs companies at Series B, Series A, Seed, Pre-seed and Late Stage (Series C+), writing tickets of $10-50 m.
Agent Capital is located in Boston, Massachusetts, United States.
Agent Capital was founded in 2016.
Agent Capital invests in companies and startups in Healthcare Services, Biotechnology, Medical Devices, Pharmaceuticals, AI, Life Sciences, HealthTech, Technology.
Agent Capital invests in companies and startups in Europe, North America, Asia.
Agent Capital invests in companies and startups at Series B, Series A, Seed, Pre-seed, Late Stage (Series C+).
Agent Capital usually invests $10-50 m on average.
Agent Capital has around $63m assets under management.
Agent Capital last fund was created/launched in 2017-06-26
Agent Capital can be reached through its website agentcapital.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Agent Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Agent Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.